The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 9
(10)
◽
pp. 962-972
◽
2019 ◽
Keyword(s):
1994 ◽
Vol 10
(1)
◽
pp. 7-14
◽
2015 ◽
Vol 34
(1)
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):